{ "resourceType" : "PublicationRecord", "resourceDefinition" : "http://hl7.org/fhir/StructureDefinition/PublicationRecord|1.0.0-snapshot", "id" : "58", "meta" : { "versionId" : "32", "lastUpdated" : "2025-10-13T16:59:33.089Z" }, "language" : "en", "text" : { "status" : "extensions", "div" : "

Generated Narrative: PublicationRecord 58

version: 32; Last updated: 2025-10-13 16:59:33+0000

ArtifactPublicationStatus: Active

url: https://fevir.net/resources/PublicationRecord/58

identifier: FEvIR Object Identifier/58

title: Citation for FEvIR Evidence 55: 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)

status: Active

date: 2022-01-10 13:29:15+0000

author: Brian S. Alper:

publisher: Computable Publishing LLC

contact: support@computablepublishing.com

description:

This Citation Resource is referenced in an example for the EBMonFHIR Implementation Guide.

\n

UseContexts

-CodeValue[x]
*Citation Classification Type: fevir-platform-use (FEvIR Platform Use)FHIR Resource

copyright:

https://creativecommons.org/licenses/by-nc-sa/4.0/

\n

Summaries

-StyleText
*Computable Publishing

14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY) [FHIR Resource], version 4. Contributors: Brian S. Alper, Joanne Dehnbostel, Khalid Shahin [Authors]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 55. Created December 17, 2020. Revised December 21, 2020. Accessed March 13, 2021. Available at: https://fevir.net/resources/Evidence/55. Computable resource at: https://fevir.net/resources/Evidence/55.

\n

RelatesTos

-TypeTarget[x]
*Derived From14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)

citedArtifact

identifier: FEvIR Object Identifier/55

dateAccessed: 2021-03-13

version: 4

StatusDates

-ActivityActualPeriod
*Createdtrue?? --> 2020-12-17

Titles

-TypeLanguageText
*Primary titleEnglish

14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY).

\n

Abstracts

-TypeLanguageTextCopyright
*Primary human useEnglish

COVID-19 pneumonia remdesivir vs. placebo 14-day mortality (779 events among 6,744 participants, 3 randomized trials)\\nRisk ratio 0.85 (95% CI 0.74 to 0.96) in fixed-effect analysis\\nRisk ratio 0.81 (95% CI 0.60 to 1.08) in random-effects analysis

\n

https://creativecommons.org/licenses/by-nc-sa/4.0/

\n

publicationForm

PublishedIns

-TypeTitlePublisherPublisherLocation
*DatabaseFast Evidence Interoperability Resources (FEvIR) PlatformComputable Publishing LLCIpswich, MA, USA

lastRevisionDate: 2020-12-21

language: English

copyright:

https://creativecommons.org/licenses/by-nc-sa/4.0/

\n

webLocation

classifier: JSON, Computable resource

url: https://fevir.net/resources/Evidence/55

classification

type: Knowledge Artifact Type

classifier: FHIR Resource

classification

type: fhir-resource

classifier: Evidence

classification

type: defined-in-text

classifier: remdesivir, COVID-19, pharmaceutical treatment

contributorship

complete: true

entry

contributor: Practitioner Brian S. Alper

forenameInitials: BS

affiliation: Computable Publishing LLC

contributionType: Conceptualization, Data curation, Supervision

role: Author/Creator

correspondingContact: true

entry

contributor: Practitioner Joanne Dehnbostel

forenameInitials: J

affiliation: Computable Publishing LLC

contributionType: Formal analysis, Data curation

role: Author/Creator

correspondingContact: false

entry

contributor: Practitioner Khalid Shahin

forenameInitials: K

affiliation: Computable Publishing LLC

contributionType: Software

role: Author/Creator

correspondingContact: false

Generated Narrative: Practitioner #contributor0

identifier: https://orcid.org//0000-0003-4300-4928

name: Brian S. Alper

telecom: balper@computablepublishing.com

Generated Narrative: Practitioner #contributor1

name: Joanne Dehnbostel

telecom: jdehnbostel@computablepublishing.com

Generated Narrative: Practitioner #contributor2

name: Khalid Shahin

telecom: kshahin@computablepublishing.com

" }, "contained" : [{ "resourceType" : "Practitioner", "id" : "contributor0", "identifier" : [{ "system" : "https://orcid.org/", "value" : "0000-0003-4300-4928", "assigner" : { "display" : "ORCID" } }], "name" : [{ "family" : "Alper", "given" : ["Brian S."] }], "telecom" : [{ "system" : "email", "value" : "balper@computablepublishing.com" }] }, { "resourceType" : "Practitioner", "id" : "contributor1", "name" : [{ "family" : "Dehnbostel", "given" : ["Joanne"] }], "telecom" : [{ "system" : "email", "value" : "jdehnbostel@computablepublishing.com" }] }, { "resourceType" : "Practitioner", "id" : "contributor2", "name" : [{ "family" : "Shahin", "given" : ["Khalid"] }], "telecom" : [{ "system" : "email", "value" : "kshahin@computablepublishing.com" }] }], "extension" : [{ "url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status", "valueCodeableConcept" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type", "code" : "active", "display" : "Active" }] } }], "url" : "https://fevir.net/resources/PublicationRecord/58", "identifier" : [{ "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/v2-0203", "code" : "ACSN", "display" : "Accession ID" }], "text" : "FEvIR Object Identifier" }, "system" : "https://fevir.net/FOI", "value" : "58", "assigner" : { "display" : "Computable Publishing LLC" } }], "title" : "Citation for FEvIR Evidence 55: 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)", "status" : "active", "date" : "2022-01-10T13:29:15.764Z", "author" : [{ "name" : "Brian S. Alper" }], "publisher" : "Computable Publishing LLC", "contact" : [{ "telecom" : [{ "system" : "email", "value" : "support@computablepublishing.com" }] }], "description" : "This Citation Resource is referenced in an example for the EBMonFHIR Implementation Guide.", "useContext" : [{ "code" : { "system" : "http://terminology.hl7.org/CodeSystem/citation-classification-type", "code" : "fevir-platform-use", "display" : "FEvIR Platform Use" }, "valueCodeableConcept" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/citation-artifact-classifier", "code" : "fhir-resource", "display" : "FHIR Resource" }] } }], "copyright" : "https://creativecommons.org/licenses/by-nc-sa/4.0/", "summary" : [{ "style" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/citation-summary-style", "code" : "comppub", "display" : "Computable Publishing" }] }, "text" : "14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY) [FHIR Resource], version 4. Contributors: Brian S. Alper, Joanne Dehnbostel, Khalid Shahin [Authors]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 55. Created December 17, 2020. Revised December 21, 2020. Accessed March 13, 2021. Available at: https://fevir.net/resources/Evidence/55. Computable resource at: https://fevir.net/resources/Evidence/55." }], "relatesTo" : [{ "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/artifact-relationship-type", "code" : "derived-from", "display" : "Derived From" }] }, "targetReference" : { "reference" : "Evidence/55", "type" : "Evidence", "display" : "14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)" } }], "citedArtifact" : { "identifier" : [{ "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/v2-0203", "code" : "ACSN", "display" : "Accession ID" }], "text" : "FEvIR Object Identifier" }, "system" : "https://fevir.net", "value" : "55", "assigner" : { "display" : "Computable Publishing LLC" } }], "dateAccessed" : "2021-03-13", "version" : "4", "statusDate" : [{ "activity" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type", "code" : "created", "display" : "Created" }] }, "actual" : true, "period" : { "end" : "2020-12-17" } }], "title" : [{ "type" : [{ "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/title-type", "code" : "primary", "display" : "Primary title" }] }], "language" : "en", "text" : "14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)." }], "abstract" : [{ "type" : [{ "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-abstract-type", "code" : "primary-human-use", "display" : "Primary human use" }] }], "language" : "en", "text" : "COVID-19 pneumonia remdesivir vs. placebo 14-day mortality (779 events among 6,744 participants, 3 randomized trials)\\nRisk ratio 0.85 (95% CI 0.74 to 0.96) in fixed-effect analysis\\nRisk ratio 0.81 (95% CI 0.60 to 1.08) in random-effects analysis", "copyright" : "https://creativecommons.org/licenses/by-nc-sa/4.0/" }], "publicationForm" : [{ "publishedIn" : { "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/published-in-type", "code" : "D019991", "display" : "Database" }] }, "title" : "Fast Evidence Interoperability Resources (FEvIR) Platform", "publisher" : { "type" : "Organization", "display" : "Computable Publishing LLC" }, "publisherLocation" : "Ipswich, MA, USA" }, "lastRevisionDate" : "2020-12-21", "language" : ["en"], "copyright" : "https://creativecommons.org/licenses/by-nc-sa/4.0/" }], "webLocation" : [{ "classifier" : [{ "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/artifact-url-classifier", "code" : "json", "display" : "JSON" }] }, { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/artifact-url-classifier", "code" : "computable-resource", "display" : "Computable resource" }] }], "url" : "https://fevir.net/resources/Evidence/55" }], "classification" : [{ "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "code" : "knowledge-artifact-type", "display" : "Knowledge Artifact Type" }] }, "classifier" : [{ "text" : "FHIR Resource" }] }, { "type" : { "text" : "fhir-resource" }, "classifier" : [{ "coding" : [{ "system" : "http://hl7.org/fhir/fhir-types", "code" : "Evidence", "display" : "Evidence" }] }] }, { "type" : { "text" : "defined-in-text" }, "classifier" : [{ "coding" : [{ "system" : "https://fevir.net/resources/CodeSystem/179423", "code" : "defined-in-text", "display" : "Defined in text" }], "text" : "remdesivir" }, { "coding" : [{ "system" : "https://fevir.net/resources/CodeSystem/179423", "code" : "defined-in-text", "display" : "Defined in text" }], "text" : "COVID-19" }, { "coding" : [{ "system" : "https://fevir.net/resources/CodeSystem/179423", "code" : "defined-in-text", "display" : "Defined in text" }], "text" : "pharmaceutical treatment" }] }], "contributorship" : { "complete" : true, "entry" : [{ "contributor" : { "reference" : "#contributor0", "type" : "Practitioner" }, "forenameInitials" : "BS", "affiliation" : [{ "display" : "Computable Publishing LLC" }], "contributionType" : [{ "coding" : [{ "system" : "http://hl7.org/fhir/artifact-contribution-type", "code" : "conceptualization", "display" : "Conceptualization" }] }, { "coding" : [{ "system" : "http://hl7.org/fhir/artifact-contribution-type", "code" : "data-curation", "display" : "Data curation" }] }, { "coding" : [{ "system" : "http://hl7.org/fhir/artifact-contribution-type", "code" : "supervision", "display" : "Supervision" }] }], "role" : { "coding" : [{ "system" : "http://hl7.org/fhir/contributor-role", "code" : "author", "display" : "Author/Creator" }] }, "correspondingContact" : true }, { "contributor" : { "reference" : "#contributor1", "type" : "Practitioner" }, "forenameInitials" : "J", "affiliation" : [{ "display" : "Computable Publishing LLC" }], "contributionType" : [{ "coding" : [{ "system" : "http://hl7.org/fhir/artifact-contribution-type", "code" : "formal-analysis", "display" : "Formal analysis" }] }, { "coding" : [{ "system" : "http://hl7.org/fhir/artifact-contribution-type", "code" : "data-curation", "display" : "Data curation" }] }], "role" : { "coding" : [{ "system" : "http://hl7.org/fhir/contributor-role", "code" : "author", "display" : "Author/Creator" }] }, "correspondingContact" : false }, { "contributor" : { "reference" : "#contributor2", "type" : "Practitioner" }, "forenameInitials" : "K", "affiliation" : [{ "display" : "Computable Publishing LLC" }], "contributionType" : [{ "coding" : [{ "system" : "http://hl7.org/fhir/artifact-contribution-type", "code" : "software", "display" : "Software" }] }], "role" : { "coding" : [{ "system" : "http://hl7.org/fhir/contributor-role", "code" : "author", "display" : "Author/Creator" }] }, "correspondingContact" : false }] } } }